Raif Derrazi Interviews Jeff Galvin on HIV Clinical Trial Updates & Addimmune


CEO Jeff Galvin joins HIV activist and Youtube creator Raif Derrazi to discuss the launch of Addimmune™ – a new HIV-focused spinoff company that will focus solely on advancing an HIV cure, building upon more than a decade of work by American Gene Technologies® (AGT™). Galvin provides insights on data from AGT’s HIV Phase I clinical trial, as well as why Addimmune was created to continue the HIV research.

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!